Particles for Humanity Reveals Breakthrough in Vitamin A Stability for Food Fortification
Particles for Humanity's Breakthrough in Vitamin A Stability
Particles for Humanity, a biotechnology firm focused on developing nutrition solutions for low- and middle-income countries, recently shared an important advancement in its research through an article published in Food Sciences & Nutrition. The paper highlights a remarkable improvement in the stability of vitamin A, essential for food fortification, especially in regions like West Africa where vitamin A deficiency poses a significant public health risk.
Vitamin A plays a vital role in maintaining good health, and its deficiency can lead to severe health issues, notably among vulnerable populations such as children and pregnant women. In response to this pressing issue, the team at Particles for Humanity explored innovative ways to encapsulate vitamin A to enhance its durability. The challenge was to find a suitable delivery method that can tolerate the environmental conditions prevalent in West Africa, characterized by high temperatures and humidity.
The study focused on the application of two formulations, known as PFH-VAP, which were added to bouillon cubes—a widely consumed food in West Africa. After a rigorous testing phase involving 12 months of storage under challenging high-temperature and high-humidity conditions, the PFH-VAP-fortified bouillon demonstrated over three times the retention of vitamin A compared to a conventional product.
This achievement has been possible thanks to a unique formulation that incorporates basic methacrylate copolymer (BMC). BMC is a well-regarded material in the pharmaceutical and nutraceutical industries, boasting over sixty years of safe usage in humans. By using BMC, PFH-VAP provides a protective barrier that preserves vitamin A during both storage and cooking processes, paving the way for effective food fortification methods in challenging climates.
The research phase necessitated substantial collaboration, exemplified by partnerships with established entities like LIS by Lesaffre, which handled spray drying operations in France, and Eurofins Denmark, responsible for analytical testing and stability studies. Their combined expertise was pivotal in gathering the necessary data to support the publication and substantiate the efficacy of PFH-VAP in real-world scenarios.
Sam Brady, Director of Research, Development, and Program Management at Particles for Humanity, remarked, "Ensuring vitamin A survives challenging conditions is essential for reaching the communities who need it the most. This technology brings us one step closer to delivering nutrition at scale."
Given these developments, Particles for Humanity is poised to focus on commercializing PFH-VAP and securing partnerships with food producers for bouillon fortification. The breakthroughs achieved by the organization represent years of dedicated research and an unwavering commitment to improving public health in resource-restricted settings.
Particles for Humanity aims to transform cutting-edge medical technology into practical solutions that enhance nutrition for people living in low- and middle-income countries. For more details, interested parties can visit their official website or reach out via email.
With a strong commitment to product development, driven by end-user needs and financially viable opportunities, Particles for Humanity is leading the charge against malnutrition. As they work towards implementation, the company envisions a future where essential nutrients like vitamin A are accessible and affordable for everyone, regardless of their economic circumstances.